Dr. William Pelham
Dr. Pelham¡¦s area of interest is attention Deficit/hyperactivity disorder (ADHD) in children and adolescents. He is the Director of the Center for Children and Families at UB, an interdisciplinary center with faculty and student involvement from the Departments of Psychology, Psychiatry, Pediatrics, School Psychology and Pharmacy. He has studied many facets of ADHD, including the following: (1) the nature of cognitive deficit, (2) Peer relationships, (3) diagnosis, (4) pharmacological, psychosocial, and combined treatments, (5) motivation and persistence, (6) family factors (e.g., parental alcohol problems), (7) service delivery, and (8) outcome. He has conducted much of this research through his Summer Treatment Program (STP) for children with ADHD, which has been recognized as by the American Psychological Association (APA), CHADD (Children and Adults with ADHD), and SAMHSA as a model program and is widely recognized as the state of the art in treatment for ADHD. His STP has also been employed in multiple clinical trials at the NIMH, NIDA, and SAMHSA. Dr. Pelham has authored or co-authored more than 275 professional papers dealing with ADHD and its treatment, both psychosocial and pharmacological. Dr. Pelham is a fellow of the American Psychological Association and the American Psychological Society, and past President of the Society of Child Clinical and Adolescent Psychology, the International Society for Research in Child and Adolescent Psychopathology, and the Professional Group for Attention Deficit and Related Disorders. He currently serves as a member of the Council of Representatives of the APA, as well as the APA Task Force on Medication and Psychosocial Treatments for Children. He founded and directs the biennial Niagara Conference on Evidence Based Treatments for Childhood and Adolescent Mental Health Problems He has been PI or Co¡XPI on more than 20 RO1 research grants from federal agencies (NIMH, NIAAA, NIDA, NINDS, NICHD, IES), and a like number from foundations and pharmaceutical companies. His laboratory is in the third percentile of all funded NIH labs in total funding over the past quarter century, and is 15th among 1600 clinical psychology laboratories in number of publications over the past 5 years. He has mentored numerous trainees to FIRST, K, and NRSA awards. He is currently funded by NIMH, NIAAA, NIDA, NINDS, IES, and industry. He has served as a consultant/advisor on ADHD and related topics to numerous federal agencies (NIMH, NIAAA, NIDA, IOM, OMAR, and the CDC) and organizations (AAP, AACAP, APA, CHADD) and pharmaceutical companies (Alza, Shire, Noven, Celltech, Abbott).
Publications, as well as helpful information for parents and teachers, can be viewed at http://wings.buffalo.edu/adhd.
Department of Psychology, University at Buffalo, The State University of New York
Send comments to: email@example.com | Last updated: April 13, 2006